Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
We are seeking to appoint a Senior Bioinformatician to lead and develop cutting-edge research into genome regulation and identification of novel therapeutic targets for rare disease. You will join
-
corresponding communications plan (including digital content) for the Faculty’s target widening participation audience; develop materials that can be used on the Faculty’s website; overseeing the recruitment
-
makers in target countries, leading global academics, and international organisations. This will involve updating the Hub’s website and social media channels, creating and disseminating content, overseeing
-
research expert responsible for managing their own project and targeting external funding for the Hub beyond the initial fixed term of this contract. This role arises from the growing importance of AI
-
the sustainability of the Centre: KPIs/targets will include: • Increase in Industry Partnerships • Increase in funding • Development/expansion of funding models • Volume and visibility of thought leadership outputs
-
use computational approaches to mine natural biodiversity in gene sequences to identify engineering targets to increase lipid content and enhance the water use efficiency. The project will make use
-
to understand how antibiotics affect target strains of interest within gut microbial communities in vitro. This will include microbiology techniques such as anaerobic culturing, serial dilution spot plating
-
UK Research and Innovation and many of the institutions hosting UKRI funded research are committed to ambitious net zero targets. At the same time, we are seeing an increasing reliance on research
-
• Contribute to the development and validation of a library of hybrid nanomaterials functionalised for targeting specialised cells working in collaboration with the team • Manage your own research
-
-dopamine neurons from Parkinson’s patients and controls to target the pathological protein alpha-synuclein. You will treat neurons with peptides targeting alpha-synuclein and use cellular assays to test for